COMPANY

About Us

We make genomics accessible for everyone

Dante Genomics is a leading global genomics and precision medicine company working to accelerate science to deliver better healthcare and ultimately save lives with a more human approach to health.

Our mission is to leverage whole genome sequencing technology and variant interpretation, so that you can make informed decisions about your health and your future.

We are a global genomics and precision medicine company.
image andrea riposati
ANDREA RIPOSATI
Chief Executive Officer
image dna sequencing
100%

Quality services for any need

5M

5.000.000+ Covid Samples​

4.7

200+ Reviews

6

Active in 6 countries

A Few Words About Us

Our Story

Founded by two Italian co-founders in 2016, the company name, Dante Genomics, comes from the compound of humanity and science. “Dante” refers to the famous Italian humanitarian poet and “Genomics” refers to the powerful science that takes place in a genomics lab. Since its foundation, Dante Genomics has delivered hundreds of thousands of people with affordable, quality genomic solutions to inform their healthcare decisions. The Company’s holistic approach to medicine spans from sequencing and variant interpretation to drug discovery and development.

2016
Founded by two Italian co-founders

2017
Lower the price of Whole Genome Sequencing (WGS) and interpretation

2018
Expands its full DNA test with proprietary analysis of Mitochondrial and Neurological diseases

2019
Launch of the first Whole Genome Report powered by Artificial Intelligence

2020
Best in class Covid analysis service provider

2021
Acquires Cambridge Cancer Genomics to create Global excellence in precision oncology

2022
Expansion of its Whole Genome Sequencing test with Enhanced and broader offering

image andrea riposati
“Our mission is to leverage whole genome sequencing technology and variant interpretation, so that you can make informed decisions about your health and your future.”

ANDREA RIPOSATI

image dubai site

Founders & Labs

Our mission is to leverage whole genome sequencing technology and variant interpretation, so that you can make informed decisions about your health and your future.

Chief Executive Officer & Co-founder

Chief Scientific Officer & Co-founder

WHAT WE DO

Personalized medicine needs personalized data

Software

Take raw data and translate that intro clinical decision-making tools and reports

Diagnostics

Analyze and interpret the whole genome to diagnose and inform on heritable diseases

Drug Development

Utilize genomic data to create novel drugs and therapies in order to better treat disease